Copernicus Therapeutics
Copernicus Therapeutics, Inc. (CTI) is a clinical stage biopharmaceutical company and a leader in the emerging field of precision medicine and gene therapy. Through their proprietary, non-viral, nucleic acid nanoparticle platform, they are able to achieve robust gene transfer in several tissues without the immune response and limited treatment window of AAV.
Industries
biotechnology
Nr. of Employees
small (1-50)
Copernicus Therapeutics
Products
Compacted Nanoparticle Delivery System
A gene therapy delivery platform using compacted nucleic acid nanoparticles designed for efficient gene transfer and repeat dosing without immune response.
Compacted Nanoparticle Delivery System
A gene therapy delivery platform using compacted nucleic acid nanoparticles designed for efficient gene transfer and repeat dosing without immune response.